Development and validation of a prognosis model for low-grade gliomas based on metabolic gene risk scoring and immune microenvironment interaction.

Discov Oncol · 2026 · PMC12992800 · PMID 41665790

Europe PMC DOI

hedged sentence

0.1330

closest p · 2.7× alpha

0.1330

boldest claim

The sentences

did not reach statistical significanceP = 0.133not close (p > 0.1)

Notably, within the IDH1 wild-type subgroup, patients with the low GPM-high MTC subtype exhibited the lowest mortality rate (33.3%), though this difference did not reach statistical significance (HR = 0.513, 95% CI: 0.215–1.224, P = 0.133).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.